Based on the key indicators related to Rxsight's liquidity, profitability, solvency, and operating efficiency, Rxsight is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, Rxsight's Accumulated Other Comprehensive Income is comparatively stable compared to the past year. Property Plant Equipment is likely to gain to about 11.8 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 17.4 M in 2025. Key indicators impacting Rxsight's financial strength include:
The essential information of the day-to-day investment outlook for Rxsight includes many different criteria found on its balance sheet. An individual investor should monitor Rxsight's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Rxsight.
Please note, the imprecision that can be found in Rxsight's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Rxsight. Check Rxsight's Beneish M Score to see the likelihood of Rxsight's management manipulating its earnings.
Rxsight Stock Summary
Rxsight competes with Axogen, Treace Medical, Pulmonx Corp, Orthofix Medical, and Orthopediatrics Corp. RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses used in cataract surgery in the United States and internationally. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. Rxsight operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 221 people.
The reason investors look at the income statement is to determine what Rxsight's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Rxsight's current stock value. Our valuation model uses many indicators to compare Rxsight value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rxsight competition to find correlations between indicators driving Rxsight's intrinsic value. More Info.
Rxsight is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Rxsight's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Rxsight by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Rxsight Systematic Risk
Rxsight's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Rxsight volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Rxsight correlated with the market. If Beta is less than 0 Rxsight generally moves in the opposite direction as compared to the market. If Rxsight Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Rxsight is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Rxsight is generally in the same direction as the market. If Beta > 1 Rxsight moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Rxsight Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rxsight's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Rxsight growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Rxsight help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Rxsight. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rxsight based on widely used predictive technical indicators. In general, we focus on analyzing Rxsight Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rxsight's daily price indicators and compare them against related drivers.
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.